Results 241 to 250 of about 2,367,896 (336)
Molecular cancer prevention: Intercepting disease
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco +2 more
wiley +1 more source
Adjusting for principal components can induce collider bias in genome-wide association studies. [PDF]
Grinde KE +4 more
europepmc +1 more source
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary +1 more
wiley +1 more source
Extracting actigraphy-based walking features with structured functional principal components. [PDF]
Werkmann V, Glynn NW, Harezlak J.
europepmc +1 more source
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel +12 more
wiley +1 more source
AliHabibnia/pca_nl_test: A Nonlinearity Test for Principal Component Analysis
Ali Habibnia, Eghbal Rahimikia
openalex +1 more source
Principal Component and Cluster Analysis of Fibre Yield in Roselle (Hibiscus sabdariffaL.)
Hariram Kumar Bandi, A. Appalaswamy
openalex +1 more source
Trend and principal components of HIV/AIDS among adults in SSA. [PDF]
Hailu BA.
europepmc +1 more source
Emerging strategies to target metastasis and therapy resistance in melanoma
Emerging studies propose new approaches to interfere with melanoma progression. In recognition of melanoma awareness month, at Molecular Oncology, we highlight recently published research articles, focusing on novel therapeutic targets driving metastatic spread and outlining different strategies to overcome resistance to BRAF inhibitors and anti‐PD‐1 ...
Amel Aziba
wiley +1 more source
Exploring Factors Influencing Driving Simulator Performance in Patients With Acquired Brain Injury Using Hierarchical Clustering Analysis of Principal Components. [PDF]
Takehara S +6 more
europepmc +1 more source

